Patent · US Active

Immunoglobulin chimeric monomer-dimer hybrids

US9636416B2 · kind B2 · utility

20Cited by
79References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2014
Grant dateMay 2, 2017
Priority date
Expiry dateOct 31, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a chimeric monomer-dimer hybrid protein wherein the protein comprises a first and a second polypeptide chain, the first polypeptide chain comprising at least a portion of an immunoglobulin constant region and a biologically active molecule, and the second polypeptide chain comprising at least a portion of an immunoglobulin constant region without the biologically active molecule of the first chain. The invention also relates to methods of using and methods of making the chimeric monomer-dimer hybrid protein of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.